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PDGF and TGF.j mediate collagen production by mesangial cells
exposed to advanced glycosylation end products. Deposition of type III
collagen protein is increased when cultured rat mesangial cells are
cultured in media containing high glucose concentrations. Possible mech-
anisms for this effect include the production of growth factors, such as
PDGF and TGF-p, and the formation of abnormal glucose-protein
adducts called advanced glycosylation end products (AGEs). In our
studies, neutralizing antibodies to PDGF and TGF-f3 prevented increased
type III collagen deposition by mesangial cells exposed either to high
glucose media or to low glucose media containing AGEs. Daily addition of
PDGF or TGF-f3 stimulated type III collagen production. However, while
co-incubation with the TGF-/3 Ab prevented PDGF-stimulated type III
collagen production, the PDGF Ab did not prevent TGF-/3-stimulated
type III collagen production. Daily addition of PDGF or TGF-p stimu-
lated, while AGEs inhibited, mesangial cell proliferation after 96 hours.
We propose that high extracellular glucose and AGEs stimulate type III
collagen production by pathways that involve the intermediate formation
of PDGF and TGF-13 by mesangial cells. PDGF may increase type III
collagen production by stimulating the intermediate production of TGF-p.
Exposure to high glucose, AGEs, or TGF-13 also leads to impaired
mesangial cell proliferation. The autocrine effects of TGF-j3 and PDGF
play important roles in the effects of high extracellular glucose and AGEs
on cultured mesangial cells.
Diabetic nephropathy is characterized by the abnormal depo-
sition of matrix in the mesangium of the glomerulus, leading to
glomeruloscierosis and loss of glomerular function [1]. While this
expansion of matrix deposition is accompanied by a modest
expansion of mesangial cell number [21, it is the deposition of
abnormal amounts and types of matrix that are the hallmarks of
diabetic glomerular disease [3, 4]. Immunohistochemical exami-
nation of renal biopsies from individuals with diabetic nephropa-
thy reveals an increase in deposition of fibronectin, and type III
and IV collagen in the glomerular mesangium. These matrix
proteins are secreted by the cells of the glomerulus, including the
mesangial cells (mesangial cells) [5]. Mesangial cells cultured in
high glucose media (HG) produce increased amounts of matrix
components [6—8]. This effect of high glucose to stimulate matrix
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production is seen after 96 hours of incubation, suggesting a
possible role for intermediate compounds in mediating these
effects of glucose. Wolf et al have shown that exposure of
mesangial cells to high extracellular glucose leads to increased
expression of mRNA for transforming growth factor-31 (TGF-p),
and that neutralizing antibodies to TGF-f3 can reverse the inhibi-
tion of mesangial cell proliferation normally seen in response to
high glucose [9, 101. The investigators proposed that the increased
matrix formation produced by mesangial cells exposed to HG is
mediated by the autocrine effects of TGF-/3. This hypothesis is
supported by their later work [11] and by the work of Yamamoto
et al, demonstrating that the glomeruli of diabetic rats display
increased expression of mRNA for TGF-p [12]. Nakamura et al
have also shown that high glucose causes increased expression of
both TGF-/3 and platelet-derived growth factor-B chain (PDGF)
mRNA in the glomeruli of rats with streptozotocin-induced
diabetes [131.
Other researchers have focused their attention on the actions of
non-enzymatically glycosylated proteins called advanced glycosyl-
ation end products (AGEs) as possible intermediates in the effects
of high glucose. These products, formed when proteins are
exposed to high glucose concentrations, interact with a specific
class of cell-surface receptor found on several cell types, including
mesangial cells [14]. AGEs stimulate the production of PDGF by
monocytes [15], and Doi et al has proposed a role for PDGF in
mediating abnormal matrix synthesis by mesangial cells in re-
sponse to AGEs [16]. AGEs stimulate matrix production and
inhibit proliferation by mesangial cells [17, 181.
Because PDGF and TGF-p have been individually implicated
in the actions of high extracellular glucose and/or AGEs on
mesangial cells, a combined role for the two growth factors in the
effects of high extracellular glucose and AGEs on cultured
mesangial cells was examined. The effect of exogenous PDGF and
TGF-/3 on collagen deposition and cellular proliferation by me-
sangial cells was also assessed. Type III collagen deposition by
mesangial cells exposed to either high extracellular glucose or
AGEs was measured, in the presence and absence of neutralizing
antibodies to TGF-/3 and PDGF. Our results suggest that PDGF
and TGF-13 play important roles in the abnormal matrix produc-
tion by mesangial cells exposed to either high glucose or AGEs,
and that TGF-/3 is an important mediator of the effects of PDGF
on mesangial cell matrix production.
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Methods
Isolation and culture of mesangial cells
Mesangial cells were obtained from the isolated glomeruli of
young male rat kidneys according to previously described proto-
cols of sieving and centrifugation for the preparation of primary
mesangial cell culture [19, 20]. Our studies employed subcultures
of the fifth to eighth passages of mesangial cells grown at 37°C in
5% CO-95% air. Routine identification of the mesangial cells
was performed by indirect immunofluorescence microscopy using
antibodies against smooth muscle actin and Thy-1.1. The mesan-
gial cells were grown in Dulbecco's Modified Eagle Medium
(DMEM) containing 10% heat-inactivated fetal calf serum (FCS),
5 g/ml insulin, 5 .tg/ml transferrin, 5 ng/ml selenous acid, 10 mM
L-glutamine, 5 JIM sodium pyruvate, 5.5 mi glucose, 400 ng/mI
penicillin, 500 ng/ml streptomycin. Confluent cells were washed
twice with phosphate-buffered saline prior to the addition of the
experimental conditions. For matrix studies mesangial cells were
also cultured in 50 JIg/ml ascorbic acid, and 50 tg/ml -aminopro-
pionitrile [211.
Model system
Neutralizing antibodies directed against TGF-p and PDGF
were added individually and in combination to mesangial cells
incubated in 5.5 m glucose media containing 0.5% FCS (LG), 25
m glucose media containing 0.5% FCS (HG), or 5.5 m glucose
media containing 0.5% FCS and 50 JIg/ml AGEs (AGEs). After
treatment, the amount of type III collagen in the cell layers was
measured, reflecting changes in the balance between synthesis and
degradation of type III collagen by the mesangial cells. The results
were first expressed as micrograms of protein/DNA for each
experimental condition. Next, this ratio was compared in control
and stimulated cells, and the results expressed as a percent of the
control.
For all experiments the cells were plated at an initial density of
20,000 cells/well in 6-well plates (Falcon, Becton Dickinson Lab-
ware, Lincoln Park, NJ, USA). We used confluent, quiescent
mesangial cells in 0.5% FCS containing insulin. We chose these
conditions for several reasons. First, we were interested in study-
ing a model of non-insulin-dependent diabetes, in which insulin
concentrations are elevated, and so included insulin in the media.
The insulin induces a phenotypic change in mesangial cells in
culture, such that type III collagen production is increased [4].
Increased type III collagen has also been described in vivo in the
glomeruli of diabetic patients [221. Second, 0.5% FCS was used as
the minimal concentration of FCS that would allow prolonged
culture of mesangial cells without also markedly affecting matrix
synthesis. In measuring the effects of exogenous growth factors,
this low concentration of FCS also minimizes interference from
growth factors known to be present in serum (including PDGF).
Cell proliferation
For all proliferation studies, media was replaced every 48 hours,
and all test substances (such as 10% FCS, PDGF or TGF-/3) were
added in 20 d volume to obtain the desired concentration.
Control wells received only the appropriate vehicle solution. At
the time of harvesting, plates were washed with phosphate-
buffered saline and incubated in a 400 .tl mixture of trypsin/0.1%
EGTA for one hour at 37°C, which causes complete detachment
of cells. Detached cells were then resuspended with equal volumes
of 0.4% trypan blue, transferred to a counting chamber, and the
number of viable cells was counted (95% cell viability in all
experiments).
DNA content analysis
DNA content was analyzed by fluorometric measurement using
2'-[4-hydroxyphenyl]-5-[4-methyl-1-piperazinyl]-2,5 '-bi-benzimid-
azole [23]. Briefly, samples from cell layers were diluted with 2 M
NaC1 to a volume of 2 ml, and mixed with 1 JIg/ml of bisbenz-
imidazole. Fluorescence was then measured using a fluorocolo-
rimeter (American Instrument Co., Silver Springs, MD, USA).
Each assay was performed in duplicate, and a standard curve
constructed using a solution of known DNA concentration from
calf thymus DNA type 1.
Matrix production
For all experiments, media and cell layers were collected from
mesangial cells and stored at —80°C. Media was replaced for all
conditions every 48 hours. Cell layers were washed twice with
phosphate-buffered saline, then harvested in 1.0 ml of the follow-
ing buffer: 10 mivi Tris-HC1 (pH 7.4), 1 M urea, 1 mM dithiothreitol,
10 mM EDTA, and 5 .tg/ml aprotinin. Samples were assayed for
type III collagen using an ELISA inhibition assay previously
characterized in our laboratory [19, 24, 25]. Briefly, a rabbit
polyclonal antibody against type III collagen was incubated in
duplicate with serial dilutions of known concentrations of specific
collagens, and with cell layers or supernatants in 96 well plates.
The addition of glucose, fetal calf serum or cell layer digests had
no effect on the linearity, sensitivity, or specificity of the assay. The
mixtures were then transferred to collagen-coated plates and
incubated. After reaction, the plates were washed and incubated
with goat anti-rabbit IgG antibody. Pre-formed avidin-biotin
peroxidase complex was then applied to each well. After washing
thoroughly, the color reaction was developed with 0-phenylenedi-
amine dihydrochloride (0.4 mg/ml) with 0.03% H202 in phos-
phate/citrate buffer. After development, the reaction was stopped
with 2 M H2S04 and analyzed by automatic ELISA reader (Flow
Laboratory, Richmond, VA, USA).
AGE production
AGEs were formed by incubating BSA with glucose 6-phos-
phate as described previously [14, 26]. After incubation for at least
three weeks in 5% C02/95% air at 37°C, the proteins were filtered
and then dialyzed overnight against phosphate-buffered saline
(PBS) to remove non-reacted glucose 6-phosphate. Fluorescence
of the AGE products was then determined using a Perkin-Elmer
fluorescence spectrometer. Measuring fluorescence of the result-
ing glycation products, AGEs fluorescence averaged 55 fluores-
cence U/mg versus 0.6 for BSA. AGEs were stored at —20°C until
use. For the studies described below, AGEs were then used at a
concentration of 50 jig/mi, which our preliminary experiments
determined to be a maximal stimulating dose for matrix forma-
tion. In all experiments with AGEs, control cells were incubated
with equal amounts of BSA. The addition of either BSA incubated
at 37°C in PBS for three weeks or fresh BSA had similar effects on
mesangial cell proliferation and matrix production.
Materials
DMEM, FCS, insulin, penicillin, and streptomycin were ob-
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Table 1. Effect of neutralizing antibodies of PDGF and TGF-B on
collagen III production stimulated by 7 days exposure to TGF-/3 or
PDGF
Growth factor No Ab +PDGF Ab +TGF-13 Ab
Controlt 100 102 19 86 8C
PDGF 189 32C 110 26 94 27
TGF-p 214 23C 193 19 121 21
Results are expressed as percentage of collagen III in the cell layer of
control cells, measured by ELISA. Results are averages of at least three
experiments performed in duplicate.
All growth factors and antibodies were added to control media
containing 5.5 mM glucose and 0.5% FCS.
P < 0.05 vs. control cells
Fig. 1. Effect of exposure to neutralizing antibodies to PDGF and TGF-13
for seven days on the amount of collagen III in mesangial cell layers. Data are
from at least three experiments performed in duplicate. Symbols are: (LII)
LG; (•) LG + PDGF Ab; () LG + TGF Ab. *p < 0.05 vs. control.
ascorbic acid, calf thymus DNA type 1, and /3-aminopropionitrile
were purchased from Sigma (St. Louis, MO, USA). Polyclonal
antiserum to type III collagen was provided by Dr. J. Madri (Yale
University). Neutralizing antibody to PDGF-AB, and the growth
factors PDGF-BB, and TGF-/31 were purchased from Upstate
Biotechnologies Inc. (Upsala, NY, USA). Neutralizing antibody
to TGF-/3 (recognizing type 1), was purchased from R&D Systems
(Minneapolis, MN, USA). Based on the manufacturer's sugges-
tions, PDGF-AB antibody was used at a concentration of 25
xg/ml, and TGF-p antibody was used at concentration of 10
.g/ml.
Statistical analysis
All data are expressed as mean SD. Groups were compared
using ANOVA and Fisher's post-hoc test performed on raw data.
Differences were considered significant at P values < 0.05.
Results
Effect of neutralizing antibodies on matrix formation by mesangial
cells stimulated by either high extracellular glucose (HG) or AGEs
First, the effect of the neutralizing antibodies against PDGF
and TGF-f3 on baseline collagen production was assessed (Fig. 1,
Table 1). The results for these and all subsequent experiments
were first expressed as tg protein/jxg DNA for each experimental
condition. Next, this ratio was compared in control and stimulated
cells, and the results expressed as a percent of the control, After
seven days, there was significantly less type III collagen in the cell
layers of mesangial cells exposed to the TGF-f3 antibody than in
cell layers from control mesangial cells in LG media alone. The
addition of the PDGF antibody had no effect on baseline collagen
production. The addition of an antibody against IgG likewise had
no effect on collagen production.
Next, the effect of the neutralizing antibodies on collagen
deposition by mesangial cells exposed to HG was examined. When
mesangial cells were exposed to HG for seven days the amount of
type III collagen in the cell layer was 205 19% of the amount
produced by mesangial cells grown in LG (N = 24,P < 0.00 1; Fig.
2). The addition of neutralizing antibodies to either PDGF or
TGF-13 significantly inhibited this effect of HG. The addition of
PDGF and TGF-13 antibodies together reduced type III collagen
protein in the cell layer to levels 42 26% below the amount in
the cell layers of mesangial cells in LG (N 8, P < 0.05). These
effects required that the neutralizing antibodies be added daily for
at least five days.
The effect of the antibodies on type III collagen production
stimulated by AGEs was also examined. When mesangial cells
were exposed to AGEs in LG for seven days the amount of type
III collagen in the cell layer was 253 31% of the amount
produced by mesangial cells grown in LG (N = 24, P < 0.001; Fig.
3). The addition of a neutralizing antibody to PDGF or TGF-f3
prevented this increased collagen production. However, the addi-
tion of both antibodies together had no greater effect on type III
collagen production than that of either antibody added alone.
Like the effect of HG, AGEs caused increased type III collagen in
the cell layer after only five days.
Effect of TGF-13 and PDGF on type III collagen production by
mesangial cells
The effect of the two growth factors on matrix formation by
mesangial cells growth in LG media was examined. When PDGF
10 ng/ml was added daily for seven days, type III collagen protein
in the cell layer was 164 26% of mesangial cells in LG alone
(Fig. 4; N = 12, P < 0.05). The addition of 1 ng/ml TGF-/3 daily
for seven days increased type III collagen in the cell layer to 181
14% of the amount produced by mesangial cells in LG alone
(N = 16, P < 0.05). When both growth factors were added
simultaneously, type III collagen in the cell layer was increased to
270 44% of cells in LG (N = 10, P < 0.05). Mesangial cells
exposed to the combination of PDGF and TGF-13 produced
significantly more type III collagen than did cells in HG, but not
significantly more than the amount produced by cells exposed to
either PDGF or TGF-13 alone. No significant increase in the
amount of type III collagen present in the cell layer in response to
either PDGF or TGF-f3 was seen before five days, and the growth
factors had to be added every 24 hours to stimulate type III
collagen production. The addition of higher doses of PDGF (up to
100 nglml) or TGF-f3 (up to 10 nglml) had no additional effect on
type III collagen present in the cell layer. Insulin was not required
in the media for PDGF and TGF-J3 to stimulate type III collagen
production. Significant increases in type III collagen were mea-
sured after four days of exposure to TGF-/3 or PDGF.
To further study the interaction between these two growth
factors, the effect of neutralizing antibodies to PDGF or TGF-/3
on collagen synthesis stimulated by PDGF and TGF-13 was












































Fig. 3. Effect of neutralizing antibodies to PDGF and TGF-J3 on the
increased collagen III in mesangial cell layers exposed to AGEs for seven
days. Data are from three experiments, each performed in duplicate.
Symbols are: (L) LG; () LG + AGEs; (U) LG + AGEs + PDGF Ab;() LU + AGEs + TGF-f3 Ab; (U) LG + AGEs + PDGF/TGF-f3 Abs.
< 0.05 vs. control.
entirely inhibited PDGF-stimulated increases in type III collagen,
and co-incubation with the TGF-f3 antibody prevented the in-
creased type III collagen production seen when TGF-f3 was added
alone. Addition of the anti-TGF-f3 antibody along with PDGF
inhibited the expected increase in type III collagen production.
This suggests an intermediate role for TGF-p in the effects of
PDGF. However, since TGF-j3 antibody also inhibits baseline type
III collagen production (Table 1) the inhibitory effect of TGF-/3
antibody on PDGF-stimulated collagen production was not sta-
tistically significant (0.05 < P < 0.1). The addition of the
anti-PDGF antibody failed to inhibit TGF-f3-induced type III
collagen deposition (Table 1).
Effect of chronic exposure to PDGF and TGF-13 on mesangial cell
proliferation
To investigate whether the combination of these same two
growth factors might also mimic the diabetic glomerular lesion by
inducing a slow proliferation of mesangial cells, we next compared
cell number and DNA content in control (LG) cells with mesan-
gial cells exposed to high glucose (HG), PDGF and/or TGF-13 for
up to 96 hours (Tables 2 and 3). The effect of exposure to AGEs,
50 pg/mI, for up to 96 hours on cell number was also measured.
Growth factors or AGEs were added daily. As has been described
before, after 24 hours TGF-13 inhibited, while HG or PDGF
stimulated, proliferation. However, exposure to HG or TGF-13 for
72 to 96 hours was associated with decreased cell number and
DNA content. For instance, after 96 hours, cell number from
mesangial cells exposed to TGF-13, 1 ng/ml, was 17% below paired
mesangial cells exposed only to 0.5% FCS (N = 12, P < 0.05).
Compared with control, treatment with PDGF +TGF- de-
creased cell number by 36%, and DNA content by 12% after 96
hours (N = 8 for both experiments, P < 0.05). Proliferation of
cells exposed to AGEs for 96 hours, measured by cell counting,
was 76 12% of control (N> 12, P < 0.05).
Discussion
This work investigated the effects of high glucose, AGEs and
growth factors on type III collagen, an important interstitial
collagen in the mesangium in diabetes [4]. We hypothesized that
high glucose and AGEs stimulate the production of PDGF and
TGF-131, and that the combination of PDGF and TGF-J31 then
causes abnormal mesangial cell proliferation and matrix produc-
tion, mimicking the diabetic glomerulus. Our data support this
hypothesis, and also indicate that other factors, in particular the
presence of AGEs in the extracellular matrix, have important
roles in regulating collagen deposition and proliferation by
mesarigial cells exposed to high extracellular glucose.
To examine the effect of glucose, AGEs and growth factors on
collagen, we measured total type III collagen in the cell layer,
which represents the net effect of changes in rates of production
and degradation. Other investigators have reported important
changes in both production and degradation of matrix by mesan-
gial cells in high glucose [27—29]. In our experiments, we sought to
measure the balance of the two processes. The addition of a
neutralizing antibody to TGF-p reduces the amount of type III
collagen produced by mesangial cells in low glucose media
containing 0.5% FCS, suggesting that the autocrine production of









Fig. 2. The effect of neutralizing antibodies to PDGF and TGF-p on the
increased collagen III in mesangial cell layers exposed to 25 mM glucose for
seven days. Data are from five experiments, each performed in duplicate.
Symbols are: () LG; () HG; (U) HG + PDGF Ab; () HG + TGF-13
Ab; (U) HG + PDGFJTGF-p Abs. P < 0.05 vs. control.
Fig. 4. The effect of PDGF and TGF-13 on the amount of collagen III in
mesangial cell layers. Data are from four experiments, each performed in
duplicate. Symbols are: (LI) LG; () LU + PDGF; (U) LG + TGF-13; (0)
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Condition 24 hrs 48 hrs 72 hrs 96 hrs
None' 100 100 100 100












+TGF-13 1.48 0.09" 0.77 0.15" 0.76 009" 0.64 0.16"
AGEs 1.09 0.14 1.3 0.23 0.91 0.08 0.76 0.12"
Results are expressed as percentage of cell count for paired control.
Cells were plated at an initial density of 7000/cm2. Results are averages of
at least three experiments performed in duplicate.
b Growth factors and AGEs were added to control media containing 5.5
m glucose + 0.5% FCS; PDGF: 5 nglml, TGF-13: 1 ngjml, AGEs: 50
gIml.
C High glucose media containing 0.5% FCS; see Methods for detailsdP < 0.05 vs. control cells
collagen production in 0.5% FCS. Such an effect is not seen for
the PDGF antibody, which suggests that autocrine production of
PDGF (along with the small amount of PDGF present in 0.5%
FCS) does not influence baseline collagen production by mes-
angial cells.
Neutralizing antibodies to either PDGF or TGF-/3 are able to
inhibit the increased matrix formation stimulated by either high
glucose or AGEs (Figs. 2 and 3). The addition of both antibodies
together inhibits the stimulated-type III collagen production by
the mesangial cells exposed to high glucose, lowering the amount
of type III collagen in the cell layer to less than the amount
produced by control mesangial cells. Both antibodies together
also have a greater effect than either antibody alone. In contrast,
while the addition of both antibodies prevents AGEs from
increasing the amount of type III collagen in the cell layer, both
antibodies together do not cause further inhibition of type III
collagen production than either antibody alone. While these
results support a role for both PDGF and TGF-J3 in mediating
both AGE- and glucose-induced matrix production by mesangial
cells, they suggest that AGEs may stimulate matrix production, in
part, through pathways which are independent of autocrine
PDGF and TGF-p release. Using soluble AGEs, we were able to
separate the effects of HG from those of AGEs. While this would
not normally occur in the glomerulus in vivo, the presence of
AGEs might be expected to amplify the effects of high glucose on
growth factor production, and, thus, on matrix production.
We are also able to mimic the effects of high glucose or AGEs
on type III collagen deposition by adding PDGF and/or TGF-/3 to
mesangial cells. The effects of exogenous growth factors may not
be equivalent to the effects of locally produced growth factors for
several reasons. The concentration of an exogenous growth factor
is highest immediately after it is added. Also, locally produced
factors may have much smaller variation in their levels from hour
to hour. Finally, TGF-f3 is released in an inactive form whose
activation may be regulated, while exogenous TGF-J3 is constitu-
itively active. Our data using exogenous growth factors do corre-
late with our results using neutralizing antibodies. Additionally,
other laboratories have demonstrated increased matrix produc-
tion by mesangial cells upon stimulation with TGF-13 [30—341.
Table 3. Effects of high glucose, PDGF, and TGF-13 on DNA content;
growth factors were added daily for 24 to 96 hours as indicateda
Condition 24 hrs 48 hrs 72 hrs 96 hrs
Control" 2.62 0.6 2.5 0.5 3.15 0.6 2.69 0.7
HGC 4.62 0.8" 4.62 1.2" 2.13 0.9 1.63 07d
TGF-/3 2.38 1.1 1.0 0.4" 1.81 06d 1.0 05d
PDGF 2.88 0.6 3.69 0.9" 3.44 0.5 2.94 0.3
PDGF
+TGF-13 2.83 1.0 1.56 0.8" 0.94 0.2" 0.88 01d
a Results are expressed as percentage of DNA content (pg/well). Cells
were plated at an intial density of 7000/cm2. Results are averages of at
least three experiments performed in duplicate.h Growth factors were added to control media containing 5.5 mrt
glucose + 0.5% FCS. Growth factor concentrations: PDGF 5 ng/ml;
TGF-3 1 ng/ml.
C High glucose media containing 0.5% FCS; see Methods for details.dP < 0.05 vs. control cells
Both mesangial cells and osteoclasts have also been shown to
increase matrix production in response to PDGF [35, 36].
While PDGF-stimulated matrix formation is inhibited by co-
incubation with the TGF-/3 antibody, the converse is not true
(Table 1). These results suggest that a major part of the effect of
PDGF on matrix production is via the stimulation of TGF-f3
production by the mesangial cells. As has been described previ-
ously, PDGF stimulates PDGF mRNA expression by mesangial
cells [371. Other investigators have shown that the addition of
TGF-f3 to mesangial cells increases PDGF-B-chain and PDGF-B
receptor mRNA expression, while the addition of PDGF or
TGF-p for six hours did not increase TGF-13 mRNA expression
[38, 39]. In other cell systems, the addition of either PDGF or
TGF-p have been reported to increase TGF-f3 mRNA expression
[40, 41]. In the mesangial cells, the effects of the growth factors
may require incubation periods longer than six hours. In support
of a critical role for PDGF in collagen production, however, the
neutralizing antibody to PDGF alone blocks the effects of high
glucose and AGEs on collagen production. The intermediate
production of PDGF may be critical for maximal production of
TGF-/3 in response to either high glucose or AGEs.
PDGF, TGF-p, and AGEs also affect mesangial cell prolifera-
tion in culture. The daily addition of TGF-13, alone and in
combination with PDGF, inhibited mesangial cell proliferation,
similar to the effect of long-term (> 48 hr) exposure to high
glucose. This effect of TGF-13 was seen on both cell number and
in DNA content. In contrast, Haberstroh et al showed that
exposure to TGF-13 for 48 to 72 hours stimulates the proliferation
of subconfluent mesangial cells, which was associated with an
increase in PDGF-B chain and PDGF-13 receptor mRNA expres-
sion [38]. The reasons for the different results are not apparent,
but may relate to differences in the model used. Haberstroh and
colleagues added TGF-/3 once, and then measured cell number
and 3H-thymidine uptake on subconfluent mesangial cells in late
passage, while we added TGF-p daily to early passage cells. In
agreement with out findings, Wolf et al have shown that neutral-
izing antibodies to TGF-f3 reverse the impaired mesangial cell
proliferation caused by high glucose [9]. The effect of long-term
exposure to HG on mesangial cell proliferation is controversial,
and appears to depend critically on the model system used [6, 17,
Table 2. Effects of PDGF, TGF-13, and AGEs on cell number; growth
factors and AGEs were added daily for 24 to 96 hours as indicateda
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18, 19]. Our model differs from those previously used by minimiz-
ing the concentration of FCS, in order to study the effects of the
individual growth factors and AGEs.
Our findings reinforce the complexity of the responses of
mesangial cells to high extracellular glucose. The interplay of
several factors, including PDGF, TGF-13, and the abnormal
glucose-protein adducts AGEs, determine the deposition of col-
lagen and the rate of proliferation by mesangial cell exposed to
high glucose.
Acknowledgments
This work was supported by grants from the Juvenile Diabetes Foun-
dation International (M.K.), and National Institutes of Health Nephrology
Training Grant (T32-DK07276—15/15) (D.C.T.). Results of these experi-
ments have been published in part in abstract form (JASN 3:768, 1992) and
were presented at the 25th Annual Meeting of the American Society of
Nephrology in December 1992.
Reprint requests to Douglas C. Throckmorton, M.D., Medical College of
Georgia, 1120 15th Street, Room CB 2803, Augusta, Georgia 30912-3175,
USA.
References
1. SELBY JV, FITzsIMM0N5 SC, NEWMAN JM, KATZ PP, SEPE S, SHow-
STACK J: The natural histoiy and epidemiology of diabetic nephropa-
thy. JAMA 263:1954—1960, 1990
2. MAUER SM, STEFFES MW, ELLIS EN, SUTHERLAND DER, BROWN
DM, GOETZ FC: Structural-functional relationships in diabetic ne-
phropathy. J Clin Invest 74:1143—1155, 1984
3. Faux RJ, SCHEINMAN JI, MAUER SM, MICHAEL AF: Polyantigenic
expansion of basement membrane constituents in diabetic nephropa-
thy. Diabetes 32:34—39, 1983
4. Aass CK, PETERSON CV, RAUGI GJ: Phenotypic expression of
collagen types in mesangial matrix of diabetic and nondiabetic rats.
Diabetes 37:1695—1702, 1988
5. Ds.a T, SPIRO Mi, SPIRO RG: Effect of high glucose on type IV
collagen production by cultured glomerular epithelial, endothelial,
and mesangial cells. Diabetes 42:170—177, 1993
6. NANMAN NS, LEONHART KL, Coslo FG, HEBERT CL: Effects of high
glucose on cellular proliferation and fibronectin production by cul-
tured human mesangial cells. Kidney list 41:396—402, 1992
7. Ayo SH, RADNIK RA, GARONI JA, GL.Ass WF, KREISBERG JI: High
glucose causes an increase in extracellular matrix proteins in cultured
mesangial cells. Am J Pathol 136:1339—1348, 1990
8. HANEDA M, K1KKAWA R, HORIDE N, TOGAWA M, KOYA D, KAJIWARA
N, OOSHIMA A, SHIGETA Y: Glucose enhances type IV collagen
production in cultured rat glomerular mesangial cells. Diabetologia
34:198—200, 1991
9. WOLF G, SHARMA K, CHEN Y, ERICKSEN M, ZIYADEH FN: High
glucose-induced proliferation in mesangial cells is reversed by auto-
crine TGF-p. Kidney mt 42:647—656, 1992
10. ZIYADEH FN, SHARMA K, ERICKSEN M, WOLF G: Stimulation of
collagen gene expression and protein synthesis in murine mesangial
cells by high glucose is mediated by autocrine activation of transform-
ing growth factor-fl. J Clin Invest 93:536—542, 1994
11. SHARMA K, ZIYADEH FN: Renal hypertrophy is associated with
upregulation of TGF-fll gene expression in diabetic BB rat and NOD
mouse. Am J Physiol 267:F1094—F1101, 1994
12. YAMAMOTO T, NAKAMURA T, NOBLE NA, Ru05LAHTI E, BORDER
WA: Expression of transforming growth factor j3 is elevated in human
and experimental diabetic nephropathy. PNAS 90:1814—1818, 1993
13. NAKAMURA T, FUKUI M, EBIHARA I, OSADA S, NAGAOKA 1, Tom'o
Y, K0IDE H: mRNA expression of growth factors in glomeruli from
diabetic rats. Diabetes 42:450—456, 1993
14. SKOLNIK EY, YANG A, MAKITA Z, RADOFF S, KIRSTEIN M, VLASSARA
H: Human and rat mesangial cell receptors for glucose-modified
proteins: Potential role in kidney tissue remodelling and diabetic
nephropathy. J Exp Med 174:931—939, 1991
15. KIR5TEIN M, ASTON C, HINTz R, VLASSARA H: Receptor-specific
induction of insulin-like growth factor I in human monocytes by
advanced glycosylation end product-modified proteins. J Clin Invest
90:439—446, 1992
16. DOI T, VLASSARA H, KIRSTEIN M, YAMADA Y, STRIKER GE, STRIKER
U: Receptor-specific increase in extracellular matrix production in
mouse mesangial cells by advanced glycosylation end products is
mediated via platelet-derived growth factor. PNAS 89:2873—2877,
1992
17. CROWLEY ST, BROWNLEE M, EDELSTEIN D, SATRIANO JA, M0RI T,
SINGHAL PC, SCHLONDORFF DO: Effects of nonenzymatic glycosyla-
tion of mesangial matrix on proliferation of mesangial cells. Diabetes
40:540—547, 1991
18. COHEN MP, ZIYADEH FN: Amadori glucose adducts modulate mes-
angial cell growth and collagen gene expression. Kidney Int 45:475—
484, 1994
19. TAKEUCHI A, THROCKMORTON DC, BROGDEN AP, YOSHIZAWA N,
RASMUSSEN H, KASHGARIAN M: Periodic high extracellular glucose
enhances production of collagens III and IV by mesangial cells. Am J
Physiol 268:F13—F19, 1995
20. LovETr DH, RYAN JL, STERZEL RB: Stimulation of rat mesangial cell
proliferation by macrophage interleukin-1. J Immunol 131:2830—2836,
1983
21. GRINNELL F, FUKAMIZU H, PAWELEK P, NAKAGAWA 5: Collagen
processing, crosslinking, and fibril bundle assembly in matrix pro-
duced by fibroblasts in long-term culture supplemented with ascorbic
acid. Exp Cell Res 181:483—491, 1989
22. NERLICH A, SCHLEICHER E: Immunohistochemical localization of
extracellular matrix components in human diabetic glomerular le-
sions. Am J Pathol 139:889—899, 1991
23. LABARCA C, PAIGEN K: A simple, rapid, and senstive DNA assay
procedure. Anal Biochem 102:344—352, 1980
24. ISHIMURA E, STERZEL RB, BUDDE K, KASHGARIAN M: Formation of
extracellular matrix by cultured rat mesangial cells. Am J Pathol
134:843—855, 1989
25. ISHIMURA E, STERZEL RB, MoRn H, KASHGARIAN M: Extracellular
matrix protein: Gene expression and synthesis in cultured rat mesan-
gial cells. Jpn J Nephrol 34:9—17, 1992
26. EDELSTEIN D, BROWNLEE M: Mechanistic studies of advanced glyco-
sylation end product inhibition by aminoguanidine. Diabetes 41:26 —29,
1992
27. MCLENNAN SV, FISHER EJ, YUE DK, TURTLE JR: High glucose
concentration causes a decrease in mesangium degradation. Diabetes
43:1041—1045, 1994
28. KASHGARIAN M, OSHIMA 5, TAKEUCHI A, THROCKMORTON DC,
RASMUSSEN Iii: The contribution of mesangial cell collagen synthesis
to the pathogenesis of diabetic nephropathy. Contr Nephrol 107:132—
139, 1994
29. COUCHMAN JR, BEAvAN LA, MCCARTHY KJ: Glomerular matrix:
Synthesis, turnover and role in mesangial expansion. Kidney Int
45:328—335, 1994
30. NARAYANAN AS, PAGE RC, SWANSON J: Collagen synthesis by human
fibroblasts. Biochem J 260:463—479, 1989
31. PHILLIPS CL, TAJIMA 5, PINNELL SR: Ascorbic acid and transforming
growth factor-f31 increase collagen biosynthesis via different mecha-
nisms: Coordinate regulation of pro al(I) and pro al(III) collagens.
Arch Biochem Biophys 295:397—403, 1992
32. FINE A, P0LIK5 CF, SMITH BD, GOLDSTEIN RH: The accumulation of
type I collagen mRNAs in human emblyonic lung fibroblasts stimu-
lated by transforming growth factor-fl. Connective Tissue Res 24:237—
247, 1990
33. RAGHOW R, POSTLETHWAITE AE, KAsiu-OJA J, MOSES HL, KANG AH:
Transforming growth factor-fl increases steady state levels of type I
procollagen and fibronectin RNAs posttranscriptionally in cultured
human dermal fibroblasts. J Clin Invest 79:1285—1288, 1987
34. BOLLINENI JS, REDDI AS: Transforming growth factor-fl enhances
glomerular collagen synthesis in diabetic rats. Diabetes 42:1673—1677,
1993
35. HEIDENREICH 5, TEPEL M, LANG D, RAHN K-H, ZIDEK W: Differen-
tial effects of insulin-like growth factor I and platelet-derived growth
Throckmorton et al: Effect of AGEs on collagen production 117
factor on growth response, matrix formation, and cytosolic free
calcium of glomerular mesangial cells of spontaneously hypertensive
and normotensive rats. Nephron 68:481—488, 1994
36. CENTRELLA M, MCCARTHY TL, CANALIS E: Platelet-derived growth
factor enhances deoxyribonucleic acid and collagen synthesis in
osteoblast-enriched cultures from fetal rat parietal bone. Endocrinol-
ogy 125:13—19, 1989
37. SILVER BJ, JAFFER FE, ABBOUD HE: Platelet-derived growth factor
synthesis in mesangial cells: Induction by multiple peptide mitogens.
PNAS 86:1056—1060, 1989
38. HABERSTROH U, ZAHNER G, DISSER M, Twss F, WOLF G, STAHL
RAK: TGF-f3 stimulates rat mesangial cell proliferation in culture:
role of PDGF 13-receptor expression. Am J Physiol 264:F199—F205,
1993
39. KANAME S, UCHIDA 5, OGATA E, KUROKAWA K: Autocrine secretion
of transforming growth factor-13 in cultured rat mesangial cells. Kidney
mt 42:1319—1327, 1992
40. OBBERGHEN-SCHILLING EV, ROCHE NS, FLANDERS KC, SPORN MB,
ROBERTS AB: Transforming growth factor-f31 positively regulates its
own expression in normal and transformed cells. J Biol Chem 263:
7741—7746, 1988
41. KIM SJ, LAFYATIS AP, HATrORI R, KIM K-Y, SPORN MB, KARIN M,
ROBERTS AB: Autoinduction of transforming growth factor /31 is
mediated by the AP-1 complex. Mol Biol Cell 10:1492—1497, 1990
